Hemorrhagic Varicella (Varicella-Zoster Virus) with Bleeding
Varicella can rarely present with hemorrhagic complications, including bleeding disorders and disseminated intravascular coagulopathy (DIC), particularly in immunocompromised patients. [1], [2]
Clinical Assessment Priorities for Bleeding
Bleeding severity should be assessed immediately using vital signs, mental status, extent of skin/mucosal bleeding, and signs of visceral involvement (respiratory symptoms, abdominal pain, neurologic symptoms). [3], [2]
The clinical presentation should be evaluated for:
- Disseminated hemorrhagic skin lesions or rapidly progressive purpura. [1]
- Evidence of DIC or systemic coagulopathy. [2]
- Secondary bacterial complications that can worsen systemic illness. [4]
Laboratory Evaluation for Hemorrhagic Complications
A bleeding-focused laboratory assessment should include:
- CBC with platelet count. [1]
- Coagulation studies (PT/INR and aPTT) to evaluate DIC. [2]
- Basic metabolic panel as part of systemic illness assessment. [4]
Varicella confirmation should use PCR from skin lesions when results will alter management in an uncertain presentation. [5]
Antiviral Therapy for Varicella with Bleeding
Antiviral therapy should be initiated promptly in patients with suspected severe or complicated varicella. [6]
Antiviral benefit is greatest when started within the first 24 hours after rash onset. [6], [3]
Oral acyclovir or valacyclovir is recommended for patients at increased risk of moderate-to-severe disease, with infectious disease consultation recommended for complex cases. [3]
Intravenous acyclovir is preferred for severe varicella in children with advanced immunosuppression from HIV, especially with hemorrhagic or extensive skin disease. [7]
Hemodynamic and Hemostatic Support for Ongoing Bleeding
Supportive care should be provided in parallel with antiviral therapy for suspected severe varicella-associated coagulopathy. [2]
Coagulation abnormalities should be treated urgently per institutional DIC/bleeding protocols while monitoring bleeding trajectory and laboratory trends. [2]
Medication and Safety Considerations During Bleeding Episodes
Aspirin and other agents that increase bleeding risk should be avoided in varicella care. AAP Immunization Schedule resource (via CIDRAP PDF)
Antiviral administration should be adjusted for renal function when required by the selected agent and clinical setting. [6]
Infection-Control Measures During Suspected Varicella
Contagiousness persists until lesions have crusted and no new lesions appear for at least 24 hours, with strict isolation and standard precautions in healthcare settings. [2]
Treatment Setting and Specialist Involvement
Admission and urgent specialist involvement are appropriate for hemorrhagic presentations, suspected DIC, or any severe systemic involvement. [1], [3]
In immunocompromised patients, management should involve infectious disease input and close monitoring for visceral dissemination and hematologic complications. [3], [2]